The POSEIDON trial: Promoting cOllaborative Support and Education in Diabetes for minOrity ethNic groups

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN68516177

Enrollment

240

Registered

2007-01-17

Start date

2006-09-01

Completion date

Unknown

Last updated

2018-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus Nutritional, Metabolic, Endocrine Diabetes

Interventions

The intervention will have three components: 1. Professional development groups for Bilingual Health Advocates (BHAs) using a validated ?learning set? model (in which stories about clients with diabet

Eligibility

Inclusion criteria

Inclusion criteria: 1. 240 people with diabetes mellitus (either form) aged over 18 2. Referred (or self-referred) for diabetes education 3. Speak one of the languages in which story-sharing groups are offered ? that is, Urdu, Sylheti, Tamil, Somali, or English (for African-Caribbeans)

Exclusion criteria

Exclusion criteria: 1. Inability to give informed consent 2. Inability of unwillingness to do group work

Design outcomes

Primary

Measure	Time frame
United Kingdom Prospective Diabetes Study (UKPDS-2) cardiovascular risk score (a composite of blood pressure, smoking status, lipid ratio, presence of atrial fibrillation, and HbA1c)	—

Secondary

Measure	Time frame
1. HbA1c 2. Well-being 3. Self-management skills 4. Diabetes-related actions 5. Cardiovascular events	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026